Mammographic findings in different breast cancer subtypes (luminal, Her2 positive, triple negative)

被引:0
|
作者
Pourali, L. [1 ]
Sales, S. Shahid [2 ]
Taghizadeh, A. [2 ]
Pezeshkirad, M. [3 ]
Farokh, D. [3 ]
Andakhshideh, E. [4 ]
机构
[1] Mashhad Univ Med Sci, Fac Med, Dept Obstet & Gynecol, Mashhad, Iran
[2] Mashhad Univ Med Sci, Fac Med, Dept Clin Oncol, Mashhad, Iran
[3] Mashhad Univ Med Sci, Fac Med, Dept Radiol, Mashhad 4, Iran
[4] Mashhad Univ Med Sci, Mashhad 4, Iran
来源
关键词
Breast cancer; immunohistochemistry; mammography; FEATURES;
D O I
10.18869/acadpub.ijrr.16.2.251
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Prognosis and management of breast cancer are defined by different variables including histological type, grading, clinical stage, Her2+, estrogen and progesterone receptor conditions. Generally, mammography is one of the most important imaging which is done in breast cancer patients. The aim of this research was to evaluate different mammographic patterns in different breast cancer sub types. Materials and Methods: Demographic and clinicopathologic data of 128 breast cancer patients which referred to two academic hospitals were obtained from their registered files and their mammographies were reviewed by two radiologists separately. Patients were categorized into 3 groups of Luminal, triple negative and Her2+ and the checklists were filled out by research team. The mentioned data was then analyzed by the SPSS software version 16. Results: In this study we found significant difference in margins' clarity and axillary lymphadenopathy between mammographic presentations of different breast cancer subtypes (P=0.041) and (P=0.14), respectively; but the difference of other mamographic presentations including mass existence, mass size, margin type, peleomorphic calcification, micro calcification, nipple retraction, skin thickening and tissue distortion were not significantly different between three groups (P>0.05). Conclusion: Results of current study showed no significant difference between mammographic features of different invasive breast cancer subtypes except for axillary lymphadenopathy and ill-defined margins. Since the majority of patients were in premenopausal status; perhaps we can say lower sensitivity of mammography in premenopausal women couldn't accurately distinguish mammographic differences between invasive breast cancer subtypes in this study.
引用
收藏
页码:251 / 255
页数:5
相关论文
共 50 条
  • [1] Evaluation of mammographic findings in different subtypes of breast cancer (luminal-her2 positive - triple negative)
    Pourali, L.
    Taghizadeh, A.
    Elahe, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 278 - 278
  • [2] Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype
    Masumi Yanagawa
    Kenzo Ikemot
    Shigeto Kawauchi
    Tomoko Furuya
    Shigeru Yamamoto
    Masaaki Oka
    Atunori Oga
    Yukiko Nagashima
    Kohsuke Sasaki
    [J]. BMC Research Notes, 5 (1)
  • [3] Quantitative MRI features analysis for differentiation of triple negative and HER2 positive subtypes of breast cancer
    Rauch, Gaiane M.
    Li, Heng
    Zhu, Hongtu
    Adrada, Beatriz E.
    Santiago, Lumarie
    Candelaria, Rosalind P.
    Wang, Hao
    Leung, Jessica
    Thompson, Alastair
    Litton, Jennifer
    Wu, Yun
    Lim, Bora
    Moulder, Stacy
    Mittendorf, Elizabeth A.
    Yang, Wei
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [4] Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer
    Irfan Cicin
    Hakan Karagol
    Ufuk Usta
    Atakan Sezer
    Sernaz Uzunoglu
    Rusen Alas-Cosar
    Tarkan Yetisyigit
    Kazim Uygun
    [J]. Medical Oncology, 2009, 26 : 335 - 343
  • [5] Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer
    Cicin, Irfan
    Karagol, Hakan
    Usta, Ufuk
    Sezer, Atakan
    Uzunoglu, Sernaz
    Alas-Cosar, Rusen
    Yetisyigit, Tarkan
    Uygun, Kazim
    [J]. MEDICAL ONCOLOGY, 2009, 26 (03) : 335 - 343
  • [6] Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expression
    Atallah, Nehal M.
    Haque, Maria
    Quinn, Cecily
    Toss, Michael S.
    Makhlouf, Shorouk
    Ibrahim, Asmaa
    Green, Andrew R.
    Alsaleem, Mansour
    Rutland, Catrin S.
    Allegrucci, Cinzia
    Mongan, Nigel P.
    Rakha, Emad
    [J]. EUROPEAN JOURNAL OF CANCER, 2023, 195
  • [7] Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes
    Heaphy, Christopher M.
    Subhawong, Andrea Proctor
    Gross, Amy L.
    Konishi, Yuko
    Kouprina, Nina
    Argani, Pedram
    Visvanathan, Kala
    Meeker, Alan K.
    [J]. MODERN PATHOLOGY, 2011, 24 (02) : 194 - 200
  • [8] Is There a Difference in the Association between Percent Mammographic Density and Subtypes of Breast Cancer? Luminal A and Triple-Negative Breast Cancer
    Ma, Huiyan
    Luo, Jianning
    Press, Michael F.
    Wang, Yaping
    Bernstein, Leslie
    Ursin, Giske
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (02) : 479 - 485
  • [9] Neoadjuvant therapy in patients with triple negative and HER2 positive early breast cancer
    Harbeck, N.
    [J]. BREAST, 2017, 32 : S18 - S18
  • [10] Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab
    Jie Li
    Maoguang Ma
    Xuesong Yang
    Maolei Zhang
    Jingyan Luo
    Huangkai Zhou
    Nunu Huang
    Feizhe Xiao
    Bingquan Lai
    Weiming Lv
    Nu Zhang
    [J]. Molecular Cancer, 19